Depressive symptoms in mothers of infants identified as genetically at risk for type 1 diabetes

被引:15
作者
Hood, KK
Johnson, SB
Carmichael, SK
Laffel, LMB
She, JX
Schatz, DA
机构
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Pediat & Adolescent Unit,Genet & Epidemiol Sect,B, Boston, MA 02115 USA
[2] Florida State Univ, Coll Med, Dept Med Humanities & Social Sci, Tallahassee, FL 32306 USA
[3] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA
[4] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA
关键词
D O I
10.2337/diacare.28.8.1898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - This study describes maternal depression associated with newborn genetic screening for type 1 diabetes after risk notification. RESEARCH DESIGN AND METHODS - Mothers of at-risk infants (n = 192), identified through newborn genetic screening as part of the Prospective Assessment of Newborns for Diabetes Autoimmunity study, were administered a Structured telephone interview assessing maternal depressive symptoms I and 3.5 months after risk notification. Statistical analyses were conducted to examine predictors and correlates of maternal depressive symptoms. RESULTS - For the total sample, maternal depressive symptoms in response to infant risk status were not elevated at I and 3.5 months after risk notification. However, at the first interview, mothers from ethnic minority backgrounds (P < 0.002), with limited education (P < 0.001), and with postpartum depression symptomatology (P < 0.001) reported significantly more depressive symptoms in response to risk notification (r(2) = 0.354). At the second inter-view, postpartum depression symptomatology remained a powerful predictor of depressive Symptoms in response to risk notification (P < 0.001). In addition, certain coping styles (wishful thinking, self-blame, and seeking social support) were associated with increased depressive symptoms. A history of major depression was a correlate of both postpartum depressive symptomatology (r = 0.26) and maternal depressive response to risk notification (r = 0.21). CONCLUSIONS - For the most part, mothers of infants genetically at risk for type I diabetes do not appear to evidence elevated depressive symptoms. This suggests that most mothers are resilient when notified of infant risk. However, certain maternal characteristics such as ethnic minority status, less than a high school education, postpartum depression symptomatology, a history of major depression, and certain coping strategies (wishful thinking, self, blame, and seeking social support) appear to be associated with a more difficult maternal response to the news of an infants increased genetic risk for type I diabetes.
引用
收藏
页码:1898 / 1903
页数:6
相关论文
共 28 条
  • [1] THE RELATIONSHIP BETWEEN DSM-III SYMPTOM DISORDERS (AXIS-I) AND PERSONALITY-DISORDERS (AXIS-II) IN AN OUTPATIENT POPULATION
    ALNAES, R
    TORGERSEN, S
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1988, 78 (04) : 485 - 492
  • [2] [Anonymous], PSYCHOL ASSESSMENT J
  • [3] Type 1 diabetes: new perspectives on disease pathogenesis and treatment
    Atkinson, MA
    Eisenbarth, GS
    [J]. LANCET, 2001, 358 (9277) : 221 - 229
  • [4] Comparability of telephone and in-person structured clinical interview for DSM-III-R (SCID) diagnoses
    Cacciola, JS
    Alterman, AI
    Rutherford, MJ
    McKay, JR
    May, DJ
    [J]. ASSESSMENT, 1999, 6 (03) : 235 - 242
  • [5] Prospective assessment in newborns of diabetes autoimmunity (PANDA): Maternal understanding of infant diabetes risk
    Carmichael, SK
    Johnson, SB
    Baughcum, A
    North, K
    Hopkins, D
    Dukes, MG
    She, JX
    Schatz, DA
    [J]. GENETICS IN MEDICINE, 2003, 5 (02) : 77 - 83
  • [6] Psychological issues in genetic testing for breast cancer
    Carter, CL
    Hailey, BJ
    [J]. WOMEN & HEALTH, 1999, 28 (04) : 73 - 91
  • [7] FIRST M, 1909, STRUCTURES CLIN INTE
  • [8] Coping: Pitfalls and promise
    Folkman, S
    Moskowitz, JT
    [J]. ANNUAL REVIEW OF PSYCHOLOGY, 2004, 55 : 745 - 774
  • [9] Maternal anxiety associated with newborn genetic screening for type 1 diabetes
    Johnson, SB
    Baughcum, AE
    Carmichael, SK
    She, JX
    Schatz, DA
    [J]. DIABETES CARE, 2004, 27 (02) : 392 - 397
  • [10] KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8